TWST – Twist Bioscience Corporation
TWST — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
21.95
Margin Of Safety %
Put/Call OI Ratio
0.98
EPS Next Q Diff
0.01
EPS Last/This Y
-0.67
EPS This/Next Y
0.09
Price
44.57
Target Price
52.78
Analyst Recom
1.55
Performance Q
32.61
Upside
-199.8%
Beta
2.2
Ticker: TWST
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-02-27 | TWST | 46.97 | 0.49 | 0.88 | 7431 |
| 2026-03-02 | TWST | 45.9 | 0.49 | 0.13 | 7482 |
| 2026-03-03 | TWST | 46.68 | 0.49 | 16.66 | 7510 |
| 2026-03-04 | TWST | 48.12 | 0.61 | 0.17 | 8324 |
| 2026-03-05 | TWST | 48.67 | 0.61 | 0.00 | 8335 |
| 2026-03-06 | TWST | 46.94 | 0.61 | 0.05 | 8333 |
| 2026-03-09 | TWST | 48.32 | 0.61 | 0.03 | 8352 |
| 2026-03-10 | TWST | 45.38 | 0.60 | 4.59 | 8077 |
| 2026-03-11 | TWST | 46.93 | 0.64 | 0.41 | 8256 |
| 2026-03-12 | TWST | 43.09 | 0.64 | 0.18 | 8302 |
| 2026-03-13 | TWST | 43.02 | 0.64 | 0.19 | 8302 |
| 2026-03-17 | TWST | 47.31 | 0.64 | 0.08 | 8332 |
| 2026-03-18 | TWST | 44.5 | 0.80 | 0.72 | 7408 |
| 2026-03-19 | TWST | 44.82 | 0.80 | 0.09 | 7384 |
| 2026-03-20 | TWST | 42.07 | 0.79 | 0.64 | 7400 |
| 2026-03-23 | TWST | 44.47 | 1.10 | 0.23 | 5448 |
| 2026-03-24 | TWST | 47.5 | 1.07 | 0.02 | 5507 |
| 2026-03-25 | TWST | 48.65 | 1.04 | 0.12 | 5569 |
| 2026-03-26 | TWST | 46.81 | 0.98 | 0.00 | 5781 |
| 2026-03-27 | TWST | 44.56 | 0.98 | 2.33 | 5790 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-02-27 | TWST | 46.98 | 19.7 | - | -1.97 |
| 2026-03-02 | TWST | 45.90 | 19.7 | - | -1.97 |
| 2026-03-03 | TWST | 46.68 | 19.7 | - | -1.97 |
| 2026-03-04 | TWST | 48.06 | 19.7 | - | -1.97 |
| 2026-03-05 | TWST | 48.66 | 19.7 | - | -1.97 |
| 2026-03-06 | TWST | 46.94 | 19.7 | - | -1.97 |
| 2026-03-09 | TWST | 48.25 | 19.7 | - | -1.97 |
| 2026-03-10 | TWST | 45.37 | 19.7 | - | -1.97 |
| 2026-03-11 | TWST | 46.95 | 19.7 | - | -1.97 |
| 2026-03-12 | TWST | 43.07 | 19.7 | - | -1.97 |
| 2026-03-13 | TWST | 43.31 | 19.7 | - | -1.97 |
| 2026-03-17 | TWST | 47.31 | 19.7 | - | -1.97 |
| 2026-03-18 | TWST | 44.49 | 19.7 | - | -1.97 |
| 2026-03-19 | TWST | 44.85 | 19.7 | - | -1.97 |
| 2026-03-20 | TWST | 42.07 | 19.7 | - | -1.97 |
| 2026-03-23 | TWST | 44.47 | 19.7 | - | -1.97 |
| 2026-03-24 | TWST | 47.48 | 19.7 | - | -1.97 |
| 2026-03-25 | TWST | 48.65 | 19.7 | - | -1.97 |
| 2026-03-26 | TWST | 46.79 | 19.7 | - | -1.97 |
| 2026-03-27 | TWST | 44.57 | 19.7 | - | -1.97 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-02-27 | TWST | -12.47 | -1.63 | 22.20 |
| 2026-03-02 | TWST | -12.45 | 0.65 | 22.20 |
| 2026-03-03 | TWST | -12.45 | 0.65 | 22.20 |
| 2026-03-04 | TWST | -12.45 | 0.65 | 22.20 |
| 2026-03-05 | TWST | -12.45 | 0.65 | 22.20 |
| 2026-03-06 | TWST | -12.45 | 0.65 | 22.20 |
| 2026-03-09 | TWST | -12.45 | 0.65 | 22.20 |
| 2026-03-10 | TWST | -12.46 | 0.65 | 22.20 |
| 2026-03-11 | TWST | -12.46 | 0.65 | 21.72 |
| 2026-03-12 | TWST | -12.46 | 0.65 | 21.72 |
| 2026-03-13 | TWST | -12.46 | 0.65 | 21.72 |
| 2026-03-17 | TWST | -12.46 | 2.27 | 21.72 |
| 2026-03-18 | TWST | -12.46 | 2.27 | 21.72 |
| 2026-03-19 | TWST | -12.74 | 2.27 | 21.72 |
| 2026-03-20 | TWST | -12.74 | 2.27 | 21.72 |
| 2026-03-23 | TWST | -12.74 | 2.28 | 21.72 |
| 2026-03-24 | TWST | -12.80 | 2.28 | 21.72 |
| 2026-03-25 | TWST | -12.74 | 2.28 | 21.95 |
| 2026-03-26 | TWST | -12.74 | 2.28 | 21.95 |
| 2026-03-27 | TWST | -12.74 | 2.28 | 21.95 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.5
Avg. EPS Est. Current Quarter
-0.53
Avg. EPS Est. Next Quarter
-0.49
Insider Transactions
-12.74
Institutional Transactions
2.28
Beta
2.2
Average Sales Estimate Current Quarter
107
Average Sales Estimate Next Quarter
111
Fair Value
Quality Score
36
Growth Score
48
Sentiment Score
93
Actual DrawDown %
70.3
Max Drawdown 5-Year %
-91.9
Target Price
52.78
P/E
Forward P/E
PEG
P/S
6.97
P/B
5.98
P/Free Cash Flow
EPS
-1.27
Average EPS Est. Cur. Y
-1.97
EPS Next Y. (Est.)
-1.88
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-19.56
Relative Volume
0.82
Return on Equity vs Sector %
-44.1
Return on Equity vs Industry %
-27.8
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
◆
TWST
Healthcare
$44.53
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
47
Range 1M
28.7%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
-40.1%
EPS NY
34.3%
52W%
60.4%
Long-Term Value
Quality companies, undervalued
WEAK
🟡 HOLD
+18.5% upside
Upside
+18.5%
Quality
36
Twist Bioscience CorporationSector: Healthcare
Industry: Diagnostics & Research
Employees: 979
Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company has a strategic collaboration with bitBiome Inc. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
TWST
Latest News
—
Caricamento notizie per TWST…
stock quote shares TWST – Twist Bioscience Corporation Stock Price stock today
news today TWST – Twist Bioscience Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch TWST – Twist Bioscience Corporation yahoo finance google finance
stock history TWST – Twist Bioscience Corporation invest stock market
stock prices TWST premarket after hours
ticker TWST fair value insiders trading